Civil Litigation,
Government
Feb. 6, 2019
Amgen doesn’t have to disclose price increases to the state, judge rules
In a decision favoring the pharmaceutical industry, a judge has ruled recently-enacted legislation over notifying the state about prescription drug price increases doesn’t require biopharmaceutical company Amgen Inc. to publicly disclose pricing details.
LOS ANGELES -- In a decision favoring the pharmaceutical industry, a judge has ruled recently-enacted legislation over notifying the state about prescription drug price increases doesn't require biopharmaceutical company Amgen Inc. to publicly disclose pricing details.
The preliminary injunction granted by Los Angeles County Superior Court Judge Mitchell L. Beckloff is...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
Enewsletter Sign-up
Related Content
Health Care & Hospital Law, Government, Constitutional Law, Civil Litigation
State drug price law doesn’t affect interstate commerce, judge rules
By Malcolm Maclachlan
Insurance
State Farm Mutual Automobile Insurance Co. v. Garamendi
'Community Service Statement' filed by insurance companies is subject to public inspection and public disclosure.